2026 NPPES data Optometrist NPI 1366472938 O.D.
Verify on CMS →

Matthew Oblad, O.D.

Optometrist in Visalia, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 60,463 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. We show these CMS records as-is — no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
183
Medicare Part D claims · 50 beneficiaries · Optometrist avg: 257
Generic prescribing
44%
generic claims · 56% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
78.6/100
▼ 4 pts below national avg 83.1 · Above neutral
Industry payments
$15.75
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Matthew Oblad, O.D. reported a CMS MIPS final score of 78.6/100 — below the 83.1 national average — and filed 183 Medicare Part D claims in 2023.

78.6/100
MIPS score · -4 vs avg
183
Part D claims, 2023
44%
generic prescribing
$15.75
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Matthew Oblad, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 27th percentile higher than 27% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Matthew Oblad, O.D. sits

This provider among optometrist peers

Across the 6,527 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Oblad, O.D. writes more Part D claims than 30% of them and scores higher on MIPS quality than 34% — placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.949.974.899.8Part D claim volume — percentile in specialtyMIPS quality — percentilePart D claim volume — percentile in specialty: 95 · MIPS quality — percentile: 48Part D claim volume — percentile in specialty: 85 · MIPS quality — percentile: 57Part D claim volume — percentile in specialty: 57 · MIPS quality — percentile: 80Part D claim volume — percentile in specialty: 52 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 67 · MIPS quality — percentile: 83Part D claim volume — percentile in specialty: 20 · MIPS quality — percentile: 67Part D claim volume — percentile in specialty: 77 · MIPS quality — percentile: 53Part D claim volume — percentile in specialty: 73 · MIPS quality — percentile: 72Part D claim volume — percentile in specialty: 17 · MIPS quality — percentile: 52Part D claim volume — percentile in specialty: 92 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 85 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 97 · MIPS quality — percentile: 17Part D claim volume — percentile in specialty: 25 · MIPS quality — percentile: 58Part D claim volume — percentile in specialty: 65 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 38 · MIPS quality — percentile: 0Part D claim volume — percentile in specialty: 93 · MIPS quality — percentile: 0Part D claim volume — percentile in specialty: 83 · MIPS quality — percentile: 95Part D claim volume — percentile in specialty: 13 · MIPS quality — percentile: 90Part D claim volume — percentile in specialty: 33 · MIPS quality — percentile: 68Part D claim volume — percentile in specialty: 88 · MIPS quality — percentile: 15Part D claim volume — percentile in specialty: 42 · MIPS quality — percentile: 33Part D claim volume — percentile in specialty: 63 · MIPS quality — percentile: 85Part D claim volume — percentile in specialty: 12 · MIPS quality — percentile: 95Part D claim volume — percentile in specialty: 62 · MIPS quality — percentile: 18Part D claim volume — percentile in specialty: 43 · MIPS quality — percentile: 38Part D claim volume — percentile in specialty: 45 · MIPS quality — percentile: 50Part D claim volume — percentile in specialty: 78 · MIPS quality — percentile: 82Part D claim volume — percentile in specialty: 60 · MIPS quality — percentile: 63Part D claim volume — percentile in specialty: 7 · MIPS quality — percentile: 7Part D claim volume — percentile in specialty: 8 · MIPS quality — percentile: 37Part D claim volume — percentile in specialty: 10 · MIPS quality — percentile: 75Part D claim volume — percentile in specialty: 35 · MIPS quality — percentile: 95Part D claim volume — percentile in specialty: 5 · MIPS quality — percentile: 10Part D claim volume — percentile in specialty: 58 · MIPS quality — percentile: 65Part D claim volume — percentile in specialty: 48 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 100 · MIPS quality — percentile: 93Part D claim volume — percentile in specialty: 53 · MIPS quality — percentile: 30Part D claim volume — percentile in specialty: 90 · MIPS quality — percentile: 73Part D claim volume — percentile in specialty: 2 · MIPS quality — percentile: 8Part D claim volume — percentile in specialty: 68 · MIPS quality — percentile: 32Part D claim volume — percentile in specialty: 15 · MIPS quality — percentile: 40Part D claim volume — percentile in specialty: 30 · MIPS quality — percentile: 62Part D claim volume — percentile in specialty: 50 · MIPS quality — percentile: 43Part D claim volume — percentile in specialty: 45 · MIPS quality — percentile: 55Part D claim volume — percentile in specialty: 35 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 28 · MIPS quality — percentile: 60Part D claim volume — percentile in specialty: 98 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 27 · MIPS quality — percentile: 77Part D claim volume — percentile in specialty: 32 · MIPS quality — percentile: 42Part D claim volume — percentile in specialty: 82 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 0 · MIPS quality — percentile: 13Part D claim volume — percentile in specialty: 22 · MIPS quality — percentile: 45Part D claim volume — percentile in specialty: 18 · MIPS quality — percentile: 70Part D claim volume — percentile in specialty: 55 · MIPS quality — percentile: 0Part D claim volume — percentile in specialty: 40 · MIPS quality — percentile: 87Part D claim volume — percentile in specialty: 75 · MIPS quality — percentile: 5Part D claim volume — percentile in specialty: 80 · MIPS quality — percentile: 95Part D claim volume — percentile in specialty: 70 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 72 · MIPS quality — percentile: 78Part D claim volume — percentile in specialty: 3 · MIPS quality — percentile: 47Matthew Oblad, O.D. — Part D claim volume — percentile in specialty: 30 · MIPS quality — percentile: 34
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one optometrist peer from a representative sample of 60; the gold marker is Matthew Oblad, O.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

What does the federal data show about Matthew Oblad, O.D.?

Near national average

NPI registry status

Active

Issued 07/03/2006

NPI 1366472938

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

183 29% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

78.6/100 4.5 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Optometrist compares to other specialties among California providers

California providers

Largest specialties in California (% of in-state providers)

Behavior Technician — 17.3%Behavior Technician17.3%Marriage & Family Therapist — 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program — 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor — 3.9%Mental Health Counselor3.9%Pharmacist — 3.5%Pharmacist3.5%Clinical Social Worker — 3.1%Clinical Social Worker3.1%Optometrist — 0.9%Optometrist0.9%
Largest specialties in California (% of in-state providers)

Medicare quality performance — MIPS

Matthew Oblad, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

Near national average
MIPS Final Score
78.6/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 78.6/100 vs national avg 83.1

0%100%National avg83%78.6%
MIPS final score (Optometrist) — 78.6/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Matthew Oblad, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 112 N AKERS ST, Visalia, CA, 93291, with a listed phone of (559) 733-4372. NPI 1366472938 was issued on 07/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Oblad most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 183 prescription claims written by this provider, covering 50 Medicare beneficiaries and totaling roughly $45K in drug spend, split 56% brand-name and 44% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.6/100 for the 2023 performance year (Quality 100, Cost 24.8), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

112 N AKERS ST
Visalia, CA 93291

Provider Details

NPI 1366472938
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 07/03/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

78.6041
Final Score
Avg: 83.1
100
Quality
24.8487
Cost

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Oblad, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Matthew Oblad, O.D.. To verify Matthew Oblad, O.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Matthew Oblad, O.D. — brand share 56.0%
Optometrist average

56% brand-name claims vs 44% generic, on 183 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

183
Total Claims
$45K
Total Drug Cost
50
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
293
Total Day Supply
8,420
Brand vs Generic
56% brand / 44% generic
Brand Drug Cost
$44K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
1.06
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Matthew Oblad, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
82
Restasis
Cyclosporine
27
Alphagan P
Brimonidine Tartrate
11
Timolol Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How Matthew Oblad, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

Matthew Oblad, O.D.'s 183 claims are below the specialty average of 257.

Nearby Optometrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Oblad.

Compare Optometrist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Matthew Oblad, O.D.'s specialty?
Matthew Oblad, O.D. specializes in Optometrist and practices in Visalia, California. Credentials: O.D..
How much does Matthew Oblad, O.D. prescribe under Medicare Part D?
In 2023, Matthew Oblad, O.D. wrote 183 Medicare Part D claims totaling $45K in drug costs for 50 beneficiaries.
What is Matthew Oblad, O.D.'s Medicare quality score?
Matthew Oblad, O.D. has a CMS MIPS Final Score of 78.6/100 (Quality: 100, Cost: 24.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Oblad, O.D. located?
Matthew Oblad, O.D. is located at 112 N AKERS ST, Visalia, CA, 93291. Phone: (559) 733-4372.
What is Matthew Oblad, O.D.'s NPI number?
Matthew Oblad, O.D.'s National Provider Identifier (NPI) is 1366472938, issued on 07/03/2006.
Does Matthew Oblad, O.D. prescribe more brand-name or generic drugs?
Matthew Oblad, O.D.'s prescribing is 56% brand-name and 44% generic drugs by claim count, with $44K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does Matthew Oblad, O.D. prescribe most often?
Based on 2023 Medicare Part D data, Matthew Oblad, O.D.'s most frequently prescribed drugs include Latanoprost, Restasis, Alphagan P. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Oblad, O.D. accept Medicare?
Matthew Oblad, O.D. appears in CMS Medicare data with 183 Part D claims and 50 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Oblad, O.D.'s credentials?
Matthew Oblad, O.D.'s NPI is 1366472938 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.